The experimental oral partial dopamine receptor agonist racked up positive results without a new safety signal in two phase 3 trials.

A new analysis showed that hearing loss is associated with a greater risk for cognitive decline in middle-aged and older ...

Ryan Stidham, MD, MS, a leading AI researcher, shared his thoughts on how the field has evolved and where it's going, as well ...

Postmenopausal women who ate more eggs or egg nutrients were more likely to gain weight, especially those following a Western ...

A new intervention improves sleep and reduces the burden on healthcare providers who treat patients with insomnia.

The possible benefit follows similar observations in diabetes, heart failure, and kidney disease, but the potential mechanism ...

Consumption of UPFs increased body weight and energy intake in overweight and obese young men, found a small study ...

In the late 1980s, Ambros and Ruvkun were postdoctoral researchers in the laboratory of Robert Horvitz, who received the ...

Research on the role that genes play in psoriasis has led to targeted therapies to reduce symptoms and slow disease ...

The investigational IL-17A inhibitor izokibep was found to induce clear clinical responses in people with moderate to severe ...

Patients with limited-stage SCLC were randomly assigned to receive durvalumab with or without tremelimumab or placebo as ...

Pediatric patients with anterior uveitis benefitted from seeing a rheumatologist and ophthalmologist together in one visit, ...